Debiopharm and Aurigene Discovery Technologies Limited Sign Agreement for the Development and Commercialisation of Debio 1142, A Novel Inhibitor of an Undisclosed Oncology Pathway
4/14/2011 12:42:40 PM
More...
|
Debiopharm and Aurigene Discovery Technologies Limited Nominate Development Candidate
9/13/2010 3:29:04 PM
More...
|
Dr. Reddy's Laboratories Ltd. (RDY) Receives Approval for Three INDs and Announces Reorganization of Its Drug Discovery Operations; Discovery Research to Fold Into Aurigene Discovery Technologies Limited
5/22/2009 7:13:42 AM
More...
|
Debiopharm and Aurigene Discovery Technologies Limited Sign Licensing Agreement for the Development and Commercialisation of Debio 0617, a Novel Inhibitor of an Undisclosed Oncology Pathway
11/20/2008 8:16:36 AM
More...
|
Aurigene Discovery Technologies Limited Announces Discovery Collaborations With Forest Laboratories, Inc. (FRX) On Obesity Targets
2/2/2007 7:28:34 PM
More...
|
Aurigene Discovery Technologies Limited And Merck Serono Enter A Discovery Collaboration To Identify Therapeutics For Autoimmune Disorders
2/2/2007 3:10:53 PM
More...
|
Debiopharm S.A. And Aurigene Discovery Technologies Limited Enter Into Agreement To Identify And Develop Selective Compounds For Immuno-Oncology Targets
6/27/2006 11:53:14 AM
More...
|